Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H30O2 |
Molecular Weight | 314.4617 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CCC4=CC(=O)CC[C@]34C
InChI
InChIKey=RJKFOVLPORLFTN-LEKSSAKUSA-N
InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1
Molecular Formula | C21H30O2 |
Molecular Weight | 314.4617 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:16:58 UTC 2023
by
admin
on
Fri Dec 15 15:16:58 UTC 2023
|
Record UNII |
4G7DS2Q64Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
664818
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
WHO-VATC |
QG03FA04
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
NDF-RT |
N0000005934
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LIVERTOX |
803
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LOINC |
83109-9
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
82694
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
CFR |
21 CFR 556.540
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LOINC |
83110-7
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
DSLD |
4218 (Number of products:3)
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LOINC |
12820-7
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LOINC |
44729-2
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
CFR |
21 CFR 522.1940
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LOINC |
24109-1
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
CFR |
21 CFR 862.1430
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
WHO-ATC |
G03FA04
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LOINC |
14890-8
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/13/1101
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LOINC |
17483-9
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
WHO-VATC |
QG03DA04
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
CFR |
21 CFR 310.530
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
NDF-RT |
N0000005934
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LOINC |
44730-0
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LOINC |
35223-7
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
CFR |
21 CFR 862.1620
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
NCI_THESAURUS |
C2296
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
NDF-RT |
N0000175601
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
NDF-RT |
N0000005934
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LOINC |
2838-1
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
LOINC |
2839-9
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
WHO-ATC |
G03DA04
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
284809
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2377
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
17026
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
1568007
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
64377
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
PROGESTERONE
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
57-83-0
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
CHEMBL103
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
DTXSID3022370
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
4G7DS2Q64Y
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
5994
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
DB00396
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
D011374
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
100000090354
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
PROGESTERONE
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | Description: Colourless crystals or a white to slightly yellowish white, crystalline powder; odourless. Solubility: Practically insoluble in water; soluble in 8 parts of ethanol (~750 g/l) TS. Category: Progestational steroid. Storage: Progesterone should be kept in a well-closed container, protected from light. Additional information: Progesterone may exist in 2 polymorphic forms, one of which melts at about 130?C, the other at about 121?C. Definition: Progesterone contains not less than 97.0% and not more than 102.0% of C21H30O2, calculated with reference to the dried substance. | ||
|
m9159
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB10076MIG
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
2279
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
200-350-6
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
Progesterone
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
C777
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
4G7DS2Q64Y
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
417
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
3389
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
9704
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
8727
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
C400424
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY | |||
|
259409
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
ALTERNATIVE | |||
|
Progesterone (medication)
Created by
admin on Fri Dec 15 15:16:58 UTC 2023 , Edited by admin on Fri Dec 15 15:16:58 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
DERIVATIVE -> PARENT |
|
||
|
DERIVATIVE -> PARENT |
|
||
|
TARGET -> AGONIST |
IC50
|
||
|
TARGET -> AGONIST |
BINDING
IC50
|
||
|
ANALOGUE->TARGET |
|
||
|
TARGET -> AGONIST |
BINDING
IC50
|
||
|
DERIVATIVE -> PARENT | |||
|
ENZYME->SUBSTRATE |
Vmax
|
||
|
AGONIST -> TARGET |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|